These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 6830177

  • 1. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
    Lerrick AJ, Wray D, Vincent A, Newsom-Davis J.
    Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
    [Abstract] [Full Text] [Related]

  • 2. [Observation on the changes in the frequency of end-plate potentials evoked by sera with different antibodies from patients with myasthenia gravis in nerve-muscle preparation of rats].
    Lu C.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):44-6, 63. PubMed ID: 1317284
    [Abstract] [Full Text] [Related]

  • 3. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC.
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [Abstract] [Full Text] [Related]

  • 4. [A transferable "myasthenogenic" factor in the serum of patients with myasthenia gravis (author's transl)].
    Toyka KV, Drachman DB, Pestronk A, Fischbeck H, Kao I.
    J Neurol; 1976 Jun 14; 212(3):271-80. PubMed ID: 58978
    [Abstract] [Full Text] [Related]

  • 5. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
    Chiu HC, Chen ML, Tsai MC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug 14; 20(3):217-23. PubMed ID: 2827968
    [Abstract] [Full Text] [Related]

  • 6. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA, Crayton JW, Gomez CM, Richman DP.
    Ann Neurol; 1981 Jun 14; 9(6):563-8. PubMed ID: 6167199
    [Abstract] [Full Text] [Related]

  • 7. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J.
    Ann Neurol; 1991 Oct 14; 30(4):550-7. PubMed ID: 1665051
    [Abstract] [Full Text] [Related]

  • 8. Effect of myasthenic IgG on degradation of junctional acetylcholine receptor.
    Takeo G, Motomura M, Mats H, Ohishi K, Yoshimura T, Tsujihata M, Nagataki S.
    Muscle Nerve; 1993 Aug 14; 16(8):840-8. PubMed ID: 8332137
    [Abstract] [Full Text] [Related]

  • 9. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG, Lambert EH.
    Electroencephalogr Clin Neurophysiol Suppl; 1978 Aug 14; (34):469-77. PubMed ID: 220007
    [Abstract] [Full Text] [Related]

  • 10. The effects of myasthenic IgG on miniature end-plate currents in mouse diaphragm.
    Pennefather P, Quastel DM.
    Life Sci; 1980 Dec 01; 27(22):2047-54. PubMed ID: 7207007
    [No Abstract] [Full Text] [Related]

  • 11. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B, Bach JF, Morel E.
    Clin Exp Immunol; 1987 Apr 01; 68(1):130-7. PubMed ID: 3652512
    [Abstract] [Full Text] [Related]

  • 12. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME.
    Fed Proc; 1978 Dec 01; 37(14):2823-7. PubMed ID: 720635
    [Abstract] [Full Text] [Related]

  • 13. Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes.
    Shibuya N, Mori K, Nakazawa Y.
    Neurology; 1978 Aug 01; 28(8):804-11. PubMed ID: 210423
    [Abstract] [Full Text] [Related]

  • 14. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A, Cull-Candy SG, Newsom-Davis J, Trautmann A, Molenaar PC, Polak RL.
    Muscle Nerve; 1981 Aug 01; 4(4):306-18. PubMed ID: 7254233
    [Abstract] [Full Text] [Related]

  • 15. Effect of passive transfer of myasthenic serum on mechanical, electrical and neuromuscular transmission properties of mouse skeletal muscle.
    Losavio A, Muchnik S, Panizza M, Sica RE, Jauregui WO.
    Medicina (B Aires); 1989 Aug 01; 49(1):7-13. PubMed ID: 2561004
    [Abstract] [Full Text] [Related]

  • 16. A lipid-associated acetylcholine receptor as an antigen in diagnosis of myasthenia gravis.
    Raimond F, Vernet-der-Garabedian B, Morel E.
    Clin Exp Immunol; 1982 Feb 01; 47(2):345-50. PubMed ID: 7075027
    [Abstract] [Full Text] [Related]

  • 17. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T, Simpson JA.
    J Clin Lab Immunol; 1982 Nov 01; 9(2):113-7. PubMed ID: 7154056
    [Abstract] [Full Text] [Related]

  • 18. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB, Appel SH.
    Ann Neurol; 1978 Sep 01; 4(3):250-2. PubMed ID: 718136
    [Abstract] [Full Text] [Related]

  • 19. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR, Appel SH.
    Biochim Biophys Acta; 1975 May 30; 393(1):66-77. PubMed ID: 1138925
    [Abstract] [Full Text] [Related]

  • 20. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS.
    Ann Neurol; 1981 Nov 30; 10(5):437-47. PubMed ID: 7305297
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.